N-DOSE AD: A Dose Optimization Trial of Nicotinamide Riboside in Alzheimer's Disease
Conditions: Alzheimer Disease; Dementia Interventions: Other: Placebo; Dietary Supplement: Nicotinamide Riboside supplementation 1000mg daily in total; Dietary Supplement: Nicotinamide Riboside dose escalation (up to 3000 mg daily in total) Sponsors: Haukeland University Hospital; Haraldsplass Deaconess Hospital Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials